CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of Subcutaneously Administered Veltuzumab (hA20) in Patients With CD20+ Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00546793
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:32.548476+00:00
Published At: 2021-08-16T00:00:00+00:00
Record Updated At: 2021-08-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["NHL", "Lymphoma, Non-Hodgkin", "Lymphoma, B-Cell", "Lymphoma, Follicular", "Lymphoma, Intermediate-Grade", "Lymphoma, Large-Cell", "Lymphoma, Low-Grade", "Lymphoma, Mixed-Cell", "Lymphoma, Small-Cell", "Leukemia, Lymphocytic, Chronic", "Leukemia, B-Cell, Chronic", "Leukemia, Prolymphocytic", "Leukemia, Small Lymphocytic", "Lymphoma, Small Lymphocytic", "Lymphoma, Lymphoplasmacytoid, CLL", "Lymphoplasmacytoid Lymphoma, CLL", "CLL", "SLL"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-08-16"
protocolSection.identificationModule.nctId: "NCT00546793"
protocolSection.identificationModule.officialTitle: "Phase I/II Study of Subcutaneously Administered Veltuzumab (hA20) in Patients With CD20+ Non-Hodgkin\u0027s Lymphoma or Chronic Lymphocytic Leukemia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.